Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Down 35.0% in April

Revelation Biosciences, Inc. (NASDAQ:REVBW) saw a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 48,365 shares, a decline of 35.0% from the April 15th total of 74,414 shares. Based on an average daily trading volume, of 22,278 shares, the days-to-cover ratio is currently 2.2 days.

Revelation Biosciences Trading Down 6.1%

Shares of NASDAQ REVBW opened at $0.01 on Wednesday. Revelation Biosciences has a twelve month low of $0.01 and a twelve month high of $0.04. The stock has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01.

Revelation Biosciences Company Profile

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.